INOVIO Will Report Third Quarter 2024 Financial Results on November 14, 2024 By Investing.com

PLYMOUTH MEETING, Pa., November 6, 2024 /PRNewswire/ — INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect humans from HPV-related diseases, cancer and infectious diseases, today announced third-quarter financial results in 2024. released after the market closes November 14, 2024. Following the launch, INOVIO will host a live conference call and webcast on 16:30 WIB to discuss financial results and provide general business updates.

The live webcast will be available online at http://ir.inovio.com/events-and-presentations/default.aspx. This is a listening-only event but will include live Q&As with analysts. The webcast will be archived and available for replay for 90 days after the event.

About INOVIO
INOVIO is a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect humans related to HPV disease, cancer, and infectious diseases. INOVIO technology optimizes the design and delivery of innovative DNA medicines that teach the body to produce its own disease-fighting tools. For more information, visit www.inovio.com.

Contact
Media: Jennie Willson (267) 429-8567 jennie.willson@inovio.com
Investors: Thomas Hong (267) 440-4298 Thomas.hong@inovio.com



Source link

Leave a Comment

g0v g0v g0v g0v g0v g0v g0v g0v g0v g0v g0v g0v g0v g0v g0v g0v g0v g0v g0v g0v g0v g0v g0v g0v g0v g0v g0v g0v g0v g0v